Evidence map›Paper›PMID 39738642›Full record

ArticleCancer immunology, immunotherapy : CII2024

Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.

Emiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nufel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh and 11 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Emiel A De JaeghereDepartment of Medical Oncology (Route 535), Ghent University Hospital, C. Heymanslaan 10, 9000, Ghent, Belgium.
Sandra TuyaertsGynaecologic Oncology, Department of Oncology, KU Leuven, Louvain, Belgium.
An M T Van NufelAnticancer Fund (ACF), Strombeek-Bever, Belgium.
Ann BelmansBiostatistics and Statistical Bioinformatics Centre (L-BioStat), KU Leuven, Louvain, Belgium.
Kris BogaertsBiostatistics and Statistical Bioinformatics Centre (L-BioStat), KU Leuven, Louvain, Belgium.
Regina Baiden-AmissahGynaecologic Oncology, Department of Oncology, KU Leuven, Louvain, Belgium.
Lien LippensCancer Research Institute Ghent (CRIG), Ghent, Belgium.
Peter VuylstekeDepartment of Hemato-Oncology, Centre Hospitalier Universitaire Université Catholique de Louvain Namur (Sainte-Elisabeth), Namur, Belgium.
Stéphanie HenryDepartment of Hemato-Oncology, Centre Hospitalier Universitaire Université Catholique de Louvain Namur (Sainte-Elisabeth), Namur, Belgium.
Xuan Bich TrinhDepartment of Gynecologic Oncology and Senology, University Hospital Antwerp, Edegem, Belgium.
Peter A van DamDepartment of Gynecologic Oncology and Senology, University Hospital Antwerp, Edegem, Belgium.
Sandrine AspeslaghDepartment of Medical Oncology, University Hospital Brussels, Brussels, Belgium.
Alex De CaluwéDepartment of Radiation Oncology, Jules Bordet Institute, Brussels, Belgium.
Eline NaertDepartment of Medical Oncology (Route 535), Ghent University Hospital, C. Heymanslaan 10, 9000, Ghent, Belgium.
Diether LambrechtsVIB-KU Louvain Center for Cancer Biology, Leuven, Belgium.
An HendrixCancer Research Institute Ghent (CRIG), Ghent, Belgium.
Olivier De WeverCancer Research Institute Ghent (CRIG), Ghent, Belgium.
Koen K Van de VijverCancer Research Institute Ghent (CRIG), Ghent, Belgium.
Frédéric AmantGynaecologic Oncology, Department of Oncology, KU Leuven, Louvain, Belgium.
Katrien VandecasteeleCancer Research Institute Ghent (CRIG), Ghent, Belgium.
Hannelore G DenysDepartment of Medical Oncology (Route 535), Ghent University Hospital, C. Heymanslaan 10, 9000, Ghent, Belgium. hannelore.denys@ugent.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39738642
PMCPMC11685354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.